Huge News for CoreWeave Stock Investors
11/21/2025 09:38 AM • CoreWeave experienced a delay with a partner that slowed its revenue growth, but the company remains optimistic about future revenue expansion.
11/21/2025 09:38 AM • CoreWeave experienced a delay with a partner that slowed its revenue growth, but the company remains optimistic about future revenue expansion.
11/21/2025 09:36 AM • Bain Capital Public Equity acquired 199,934 shares of National Vision Holdings, representing a $5.84 million investment in the optical retail sector. The stock has performed well in 2025, with a 136% year-to-date return, and the company is focusing on cost-cutting and expansion strategies.
11/21/2025 09:34 AM • The article discusses undervalued dividend stocks that could perform well during potential economic uncertainty, highlighting that dividend stocks tend to be more stable during recessions.
11/21/2025 09:32 AM • The article compares Vanguard's VOO and Invesco's QQQ ETFs, highlighting VOO's broader diversification, lower expense ratio, and higher dividend yield, while QQQ offers more concentrated tech-driven growth with higher volatility.
11/21/2025 09:00 AM • The global GMP drug substance market is projected to grow from $2.71 billion in 2025 to $4.64 billion by 2034, with a 6.14% CAGR. North America dominates the market, driven by advanced manufacturing infrastructure and increasing demand for biologics and complex therapies.
11/21/2025 09:00 AM • Cloudastructure launches its first global guard center in Kolkata, India, expanding remote monitoring capabilities by bringing security operations in-house and leveraging AI-powered video surveillance with trained remote guards.
11/21/2025 09:00 AM • The American Kidney Fund hosted its third annual Patient Access Initiative Summit focusing on innovative kidney care technologies, AI applications, and addressing barriers to kidney disease prevention and treatment.
11/21/2025 09:00 AM • 400 cross-disciplinary leaders gathered in Los Angeles to discuss AI's transformative role in creativity, exploring how artificial intelligence is reshaping artistic production, authorship, and human expression.
11/21/2025 09:00 AM • InspireMD granted 122,054 shares of restricted stock to eight new non-executive employees under its 2024 Inducement Plan, with shares vesting over a three-year period.
11/21/2025 09:00 AM • Cabot Corporation announced the appointment of William Masterson as senior vice president and president of the Reinforcement Materials segment, succeeding Matthew Wood who is leaving the company immediately.
11/21/2025 09:00 AM • The surgical microscopes market is expected to grow from $1.51 billion in 2025 to $2.59 billion in 2030, driven by rising surgical volumes, digital integration, and healthcare infrastructure modernization across specialties like neurosurgery and dentistry.
11/21/2025 08:50 AM • FuelPositive Corporation is keeping its C$5 million non-brokered LIFE financing open to support investor engagement in its decentralized on-farm Green Ammonia strategy, with ongoing positive discussions in agriculture and clean tech communities.
11/21/2025 08:48 AM • GSK's subsidiary Tesaro has filed a lawsuit against AnaptysBio in Delaware Chancery Court, alleging breach of a license agreement for the cancer drug Jemperli, and seeking to protect its royalty rights.
11/21/2025 08:41 AM • U.S. stock futures showed mixed performance after Thursday's sell-off, with markets digesting a stronger-than-expected September jobs report and potential Federal Reserve interest rate decisions. Several companies reported earnings, with varied market reactions.
11/21/2025 08:39 AM • Fund managers warn that companies are excessively investing in AI infrastructure, with potential financial risks emerging from massive capital expenditures in data centers, GPUs, and AI development.
11/21/2025 08:37 AM • Market experienced a significant downturn as rising consumer debt, low consumer sentiment, and high margin debt created systemic financial fragility, challenging the AI investment narrative and revealing potential economic vulnerabilities.
11/21/2025 08:00 AM • Genius Group demonstrates strong management confidence through insider buying and strategic developments, including engaging Inspiral Architects for Genius City Bali project and expanding its global education initiatives.
11/21/2025 08:00 AM • Adlai Nortye, a clinical-stage biotechnology company, will participate in two healthcare investor conferences in late 2025 and early 2026, presenting its innovative cancer therapy pipeline.
11/21/2025 08:00 AM • Bitcoin Depot announced a leadership transition, with Scott Buchanan becoming CEO on January 1, 2026, while founder Brandon Mintz will continue as Executive Chairman. Elizabeth Simer was also appointed as Chief Operating Officer.
11/21/2025 08:00 AM • Esperion announced that its partner Otsuka launched NEXLETOL in Japan, receiving a $90 million payment for the cardiovascular prevention drug's national health insurance price listing and market entry.
11/21/2025 07:32 AM • Billionaire Stanley Druckenmiller invested in Amazon stock, seeing potential in its AI capabilities, AWS growth, and margin expansion. The company shows promise in cloud computing, e-commerce, and innovative projects despite current market challenges.
11/21/2025 07:00 AM • Chicago Atlantic BDC, Inc. will participate in Noble Capital Markets' 21st Annual Emerging Growth Equity Conference on December 2-3, 2025, with President Dino Colonna hosting investor meetings and presenting on December 3rd.
11/21/2025 07:00 AM • Mesa Air Group reported Q3 2025 financial results with a net loss of $14.1 million and announced the upcoming merger with Republic Airways, expected to close on November 25, 2025, with plans to trade under the Nasdaq symbol 'RJET'.
11/21/2025 07:00 AM • The High Voltage Interlock (HVIL) Connector Market is projected to grow from USD 1.35 Billion in 2024 to USD 2.65 Billion by 2032, driven by increasing electric vehicle production and safety requirements.
11/21/2025 07:00 AM • The global AI in oncology market is projected to grow from $1.95 billion in 2024 to $25.02 billion by 2034, with a 29.36% CAGR, driven by increasing cancer cases, AI innovation, and advances in precision medicine.